← SynDRA
TRIMETREXATE
SynDRA canonical compound SYN0001014 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | DHFR |
|---|
| Mechanism of action | dihydrofolate reductase inhibitor |
|---|
All known targets
- DHFR
- DFR1
- FPGS
- PDF
- dfrA17
- folA
Mechanisms of action (all sources)
- dihydrofolate reductase inhibitor
- PDF INHIBITOR
Drug classes
- Anti-Infective Agents
- Antifungal Agents
- Antimetabolites
- Antimetabolites, Antineoplastic
- Antineoplastic Agents
- Enzyme Inhibitors
- Folic Acid Antagonists
- Noxae
ATC classes
- P01A · AGENTS AGAINST AMOEBIASIS AND OTHER PROTOZOAL DISEASES
Cross-references
Synonyms
- trimetrexate hydrate
- trimetrexate glucuronate
- CI-898
- JB-11
- Trimetrexato
- NSC-249008
- TMQ
- Trimetrexatum
- Jb-11
- Trimetrexato [INN-Spanish]
- Trimetrexatum [INN-Latin]
- Trimetrexate (USAN/INN)
- Trimetrexate [USAN:BAN:INN]
- 2,4-Diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline
- 5-Methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-2,4-quinazolinediamine
- 5-methyl-6-({[3,4,5-tris(methyloxy)phenyl]amino}methyl)quinazoline-2,4-diamine
- 5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine
- 6-[((3,4,5-Trimethoxyphenyl)amino)methyl]-5-methyl-2,4-quinazolinediamine
- NSC 249008
- UPN4ITI8T4
- NSC249008
- NSC328564
- Trimexate
- Hydrate, Trimetrexate
- RefChem:899934
- DTXCID603714
- JB11
- P01AX07
- CI898
- Monohydrate, Monoacetate Trimetrexate
- CI 898
- JB 11
- Trimetrexate Hydrate
- HSDB 6545
- NCGC00161419-02
- UNII-UPN4ITI8T4
- Trimetrexate [USAN:INN:BAN]
- TRIMETREXATE [MI]
Look up TRIMETREXATE in the interactive SynDRA portal →